RecruitingNCT04724603

Phage Safety Retrospective Cohort Study


Sponsor

Hospices Civils de Lyon

Enrollment

25 participants

Start Date

Feb 1, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of this study is to determine the imputability of adverse events in patients who have had phage therapy for the treatment of their bone or joint or implant infection, in order to find out whether these adverse effects are related to surgery, antibiotic treatment or bacteriophages.


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying patients having had avderse event after phagotherapy for bone or joint or implant infection for people with bone and joint infection and prosthetic joint infection. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERpatients having had avderse event after phagotherapy for bone or joint or implant infection

to determine the accountability of adverse effects in having had avderse event after phagotherapy for bone or joint or implant infection


Locations(1)

Hospices Civils de Lyon

Lyon, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04724603


Related Trials